IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 51 filers reported holding IGM BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $45,827 | -53.2% | 4,965 | -30.3% | 0.00% | – |
| Q1 2023 | $97,870 | +8.0% | 7,123 | +33.7% | 0.00% | – |
| Q4 2022 | $90,629 | -59.2% | 5,328 | -45.4% | 0.00% | – |
| Q3 2022 | $222,000 | +107.5% | 9,762 | +64.8% | 0.00% | – |
| Q2 2022 | $107,000 | -15.7% | 5,922 | +24.9% | 0.00% | – |
| Q1 2022 | $127,000 | -17.5% | 4,742 | -9.3% | 0.00% | – |
| Q4 2021 | $154,000 | -52.9% | 5,229 | +5.2% | 0.00% | – |
| Q3 2021 | $327,000 | -23.2% | 4,969 | -3.1% | 0.00% | – |
| Q2 2021 | $426,000 | +14.2% | 5,129 | +5.3% | 0.00% | – |
| Q1 2021 | $373,000 | -53.5% | 4,873 | -46.4% | 0.00% | – |
| Q4 2020 | $803,000 | +176.9% | 9,094 | +131.3% | 0.00% | – |
| Q3 2020 | $290,000 | -4.6% | 3,932 | -5.9% | 0.00% | – |
| Q2 2020 | $304,000 | +210.2% | 4,177 | +137.9% | 0.00% | – |
| Q1 2020 | $98,000 | +42.0% | 1,756 | -4.0% | 0.00% | – |
| Q4 2019 | $69,000 | – | 1,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |